Enzo Biochem Inc (ENZ) Cumulative Dividend Pay out History TTM by Quarter, Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
• Dividend Growth
• Cumulative Pay out
Enzo Biochem Inc  (NYSE: ENZ)

 

ENZ's Dividend Pay out ratio over the 12 Months Period

Cumulative by Quarter, Trailing twelve months

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.



According to the latest data Apr 30 2025, it is not possible to calculate dividend pay out ratio.
Visit Enzo Biochem Inc Cash flow


Dividend in Glossary



Back to ENZ Dividend Comparisons >> See also ENZ's dividend growth by quarter >> See also ENZ's eps growth
Cumulative Dividend Pay out Ratio III. Quarter
(Apr 30 2025)		 II. Quarter
(Jan 31 2025)		 I. Quarter
(Oct 31 2024)		 IV. Quarter
(Jul 31 2024)		 III. Quarter
(Apr 30 2024)
ENZ's Pay out Ratio (TTM) - - - - -
ENZ's Dividend Pay out Ratio Total Ranking # # # # #

  News about Enzo Biochem Inc Dividends

Enzo Biochem’s Financial Growth Marks Promising Quarter: $0.10 Dividend Signals Strong Future Ahead,

Enzo Biochem Reports Financial Results for Q4 and Full Year 2024: Announces Dividend PayoutFARMINGDALE, N.Y. ?? Enzo Biochem, Inc. (NYSE: ENZ), a prominent player in the biotechnology and diagnostics sector, released its financial results for both the fiscal fourth quarter and the full year, both concluding on July 31, 2024. The announcement, made from its headquarters in Farmingdale, New York, underscores the company’s ongoing commitment to growth despite the challenges faced in a competitive industry.For the fourth quarter of fiscal 2024, Enzo reported total revenues of $12.5 million, showcasing a solid improvement compared to $11.2 million during the same quarter of the previous fiscal year. This 11.6% year-over-year increase reflects the company’s strategic initiatives to enhance its product offerings and respond to evolving market demands. The revenue surge can be attributed to stronger-than-anticipated performance in their diagnostic services, particularly in the area of infectious diseases, which represents a key growth segment for the company.

ENZ's Dividend Pay out Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
S&P 500 #

Dividend Pay out Ratio Statistics
High Average Low
0 % 0 % 0 %
 



Other Dividend Ratios
Highest Ranking Dividend Yield
Lowest Ranking Dividend Yield
Annual Dividend Pay out for ENZ
ENZ's Dividend Yield




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.